Publication | Open Access
Simultaneous use of erythropoietin and LFM‐A13 as a new therapeutic approach for colorectal cancer
18
Citations
48
References
2017
Year
Epo significantly enhances the antitumour activity of LFM-A13, indicating that a combination of Epo and LFM-A13 has potential as an effective therapeutic approach for patients with colorectal cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1